ArticleOncotarget2016

Responses to crizotinib in patients with ALK-positive lung adenocarcinoma who tested immunohistochemistry (IHC)-positive and fluorescence in situ hybridization (FISH)-negative.

Di Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.